Ignite Creation Date:
2024-05-06 @ 7:46 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02593435
Status:
UNKNOWN
Last Update Posted:
2016-03-24
First Post:
2015-10-29
Brief Title:
The Registration Program of BRCA12 Gene
Sponsor:
Chinese Anti-Cancer Association
Organization:
Chinese Anti-Cancer Association
Study Overview
Official Title:
The Registration Program of BRCA12 Gene in Chinese Breast Cancer Group
Status:
UNKNOWN
Status Verified Date:
2016-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RCA
Brief Summary:
Purpose
1 Screening of large samples is to search the gene mutation of the breast cancer susceptibility gene BRCA1 and BRCA2 in Chinese high risk group
2 To build the breast cancer BRCA12 mutation database of Chinese group
3 To build the hazard model of breast cancer BRCA12 mutation of Chinese group
1 Screening of large samples is to search the gene mutation of the breast cancer susceptibility gene BRCA1 and BRCA2 in Chinese high risk group
2 To build the breast cancer BRCA12 mutation database of Chinese group
3 To build the hazard model of breast cancer BRCA12 mutation of Chinese group
Detailed Description:
It is the first large-scale and systematic study that fully recognize and review on the mutation spectrum of BRCA12 and the risk of Breast cancer in Chinese high risk group it will be a Landmark research of susceptibility genes in Chinese breast cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None